FI853228L - Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.

Info

Publication number
FI853228L
FI853228L FI853228A FI853228A FI853228L FI 853228 L FI853228 L FI 853228L FI 853228 A FI853228 A FI 853228A FI 853228 A FI853228 A FI 853228A FI 853228 L FI853228 L FI 853228L
Authority
FI
Finland
Prior art keywords
deras
butyrolaktamer
farmaceutiskt
kompositioner
aktiva
Prior art date
Application number
FI853228A
Other languages
English (en)
Other versions
FI853228A0 (fi
Inventor
Chen Yan-Rong
Yang Ming-He
Huang Liang
Liu Gen-Tao
Ulrich Benz
Original Assignee
Chinese Acad Med Science
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese Acad Med Science, Bayer Ag filed Critical Chinese Acad Med Science
Publication of FI853228A0 publication Critical patent/FI853228A0/fi
Publication of FI853228L publication Critical patent/FI853228L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Package Frames And Binding Bands (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI853228A 1984-08-24 1985-08-22 Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel. FI853228L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843431257 DE3431257A1 (de) 1984-08-24 1984-08-24 Neue (delta)-butyrolactame, pharmakologisch aktive zusammensetzungen derselben, verfahren zu ihrer herstellung und ihre medizinische verwendung

Publications (2)

Publication Number Publication Date
FI853228A0 FI853228A0 (fi) 1985-08-22
FI853228L true FI853228L (fi) 1986-02-25

Family

ID=6243847

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853228A FI853228L (fi) 1984-08-24 1985-08-22 Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.

Country Status (16)

Country Link
US (1) US4879390A (fi)
EP (1) EP0172514B1 (fi)
JP (1) JPH0660159B2 (fi)
KR (1) KR860001787A (fi)
AT (1) ATE46504T1 (fi)
AU (1) AU571729B2 (fi)
CA (1) CA1262250A (fi)
DE (2) DE3431257A1 (fi)
DK (1) DK385285A (fi)
ES (2) ES8609241A1 (fi)
FI (1) FI853228L (fi)
GR (1) GR852050B (fi)
HU (1) HU195774B (fi)
IL (1) IL76157A (fi)
PT (1) PT81005B (fi)
ZA (1) ZA856414B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU579029B2 (en) * 1985-10-18 1988-11-10 Bayer Aktiengesellschaft Process for the preparation of ` -butyrolactams
DE3616989A1 (de) * 1986-05-21 1987-11-26 Bayer Ag Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung
DE3927367A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von dehydrocycloclausenamid und dessen derivate in der racemischen form und als optisch aktive (+) oder (-)-enantiomere
DE3927370A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate
JP4585073B2 (ja) * 2000-02-15 2010-11-24 丸善製薬株式会社 抗男性ホルモン剤、養毛化粧料、前立腺肥大抑制剤、外用剤及び飲食品
US6787564B2 (en) * 2002-03-26 2004-09-07 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use
EP1348696B1 (en) * 2002-03-26 2012-02-01 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same
CN1295215C (zh) * 2002-12-31 2007-01-17 中国医学科学院药物研究所 黄皮酰胺的光学活性衍生物、其制法和其药物组合物与用途
WO2016015333A1 (en) * 2014-08-01 2016-02-04 F.Hoffmann-La Roche Ag 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI325174A (fi) * 1973-11-19 1975-05-20 Sandoz Ag

Also Published As

Publication number Publication date
FI853228A0 (fi) 1985-08-22
HUT38904A (en) 1986-07-28
EP0172514A1 (en) 1986-02-26
AU4657185A (en) 1986-02-27
ES554061A0 (es) 1987-04-01
IL76157A (en) 1988-08-31
JPS62181250A (ja) 1987-08-08
IL76157A0 (en) 1985-12-31
DK385285A (da) 1986-02-25
HU195774B (en) 1988-07-28
EP0172514B1 (en) 1989-09-20
KR860001787A (ko) 1986-03-22
ES8609241A1 (es) 1986-07-16
ES546381A0 (es) 1986-07-16
DE3431257A1 (de) 1986-03-06
PT81005B (en) 1987-06-26
JPH0660159B2 (ja) 1994-08-10
DK385285D0 (da) 1985-08-23
ES8704457A1 (es) 1987-04-01
CA1262250A (en) 1989-10-10
DE3573113D1 (en) 1989-10-26
GR852050B (fi) 1985-12-20
ZA856414B (en) 1986-04-30
ATE46504T1 (de) 1989-10-15
US4879390A (en) 1989-11-07
PT81005A (en) 1985-09-01
AU571729B2 (en) 1988-04-21

Similar Documents

Publication Publication Date Title
PT82127A (en) Process for the preparation of phenyl carbamates
GB2124445B (en) Improvements in or relating to transimpedance amplifiers
IL89835A0 (en) Substituted azetidinones,their preparation and pharmaceutical compositions containing them
ZA863346B (en) Novel surface-active composition,the process for the production thereof and the uses thereof
ES543445A0 (es) Cuadro de bicicletas
ES477587A1 (es) Un procedimiento para la preparacion de 1(p-metoxibenzoil)-2-pirrolidinona.
DE2961735D1 (en) Improvements in or relating to audio teleconferencing
IT8620719A0 (it) Miglioramenti relativi al trattamento del tabacco.
FI853228L (fi) Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.
AU3979785A (en) Square prism filter, combiner, transmitter
NO865255D0 (no) Filterpresse.
IT7823336A0 (it) Composizione adatta alla riduzione del tenore di fenilalanina e metodo impiegante la stessa.
DE3689418T2 (de) Filterpresse.
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
FI853325L (fi) Filterpress.
FI864502A0 (fi) Filterbandpress.
FI861368A0 (fi) Filterpress.
IT8385632A0 (it) Pressa per produrre fiammiferi.
DE3585599D1 (de) Verbundglaszusammensetzung.
AU576294B2 (en) Improvements to filter presses
ES8609301A1 (es) Procedimiento para la obtencion de 3-metil-7-fluor-5-nitro- benzotiofeno
KR860006073U (ko) 필터프레스
IT8423324A0 (it) Filtropressa.
FR2572302B1 (fr) Filtre-presse
BR8406473A (pt) Filtro prensa

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: CHINESE ACADEMY OF MEDICAL SCIENCES

Owner name: BAYER AKTIENGESELLSCHAFT